Page results
-
UCLH is the first NHS centre in the UK to offer patients suffering from obstructive sleep apnœa (OSA) a choice of nerve stimulation devices to manage their condition.
-
UCLH today marks International Clinical Trials Day, which this year coincides with the National Institute for Health Research (NIHR) campaign encouraging everyone to ‘Be Part of Research.’
-
Meet Mohammod, a booking coordinator in our Proton Beam Therapy unit, who supports patients and their families throughout their treatment.
-
We are expanding the type of results that will be shared with patients through our patient portal MyCare UCLH.
-
A high quality diagnostic service for surgical neuropathology, neuromuscular diagnostics, epilepsy, molecular neuropathology of brain tumours, and neurodegenerative diseases.
-
Information about the Integrated General Medicine Service at the RLHIM patient information leaflet.
-
Information supporting adults affected by cancer and blood conditions being treated at UCLH.
-
Information for patients having chemotherapy for ovarian, tubal or primary peritoneal cancer, or who have been newly diagnosed with pancreatic cancer or cholangiocarcinoma.
-
This page has been written by the Neuropsychiatry Department at the National Hospital for Neurology and Neurosurgery. The aim of this page is to provide general information about the procedure called Repetitive Transcranial Magnetic Stimulation (rTMS).
-
This information has been written for patients who have been referred for High Dose Rate (HDR) brachytherapy to the oesophagus (gullet).
File results
-
FOI/2023/0591 - Healthcare Assistants agency rates 2023
-
FOI/2023/0592 - Procurement staff organisation chart
-
FOI/2023/0603 - Treatment of dermatological conditions
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer
-
FOI/2024/0361 - Recording RTT waiting times: Planned patients guidance
-
FOI/2024/0360 - Radiology Information System (RIS) supplier/ contract/ staff details
-
FOI/2024/0357 - Multiple myeloma treatments
-
FOI/2024/0363 - Freedom of Information responses available for Mesh requests
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0532 - Patient treatment/ care/ consent